Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 116
Filter
Add more filters










Publication year range
1.
PLoS One ; 9(5): e96909, 2014.
Article in English | MEDLINE | ID: mdl-24816799

ABSTRACT

Capsazepine (CPZ) inhibits Na+,K+-ATPase-mediated K+-dependent ATP hydrolysis with no effect on Na+-ATPase activity. In this study we have investigated the functional effects of CPZ on Na+,K+-ATPase in intact cells. We have also used well established biochemical and biophysical techniques to understand how CPZ modifies the catalytic subunit of Na+,K+-ATPase. In isolated rat cardiomyocytes, CPZ abolished Na+,K+-ATPase current in the presence of extracellular K+. In contrast, CPZ stimulated pump current in the absence of extracellular K+. Similar conclusions were attained using HEK293 cells loaded with the Na+ sensitive dye Asante NaTRIUM green. Proteolytic cleavage of pig kidney Na+,K+-ATPase indicated that CPZ stabilizes ion interaction with the K+ sites. The distal part of membrane span 10 (M10) of the α-subunit was exposed to trypsin cleavage in the presence of guanidinum ions, which function as Na+ congener at the Na+ specific site. This effect of guanidinium was amplified by treatment with CPZ. Fluorescence of the membrane potential sensitive dye, oxonol VI, was measured following addition of substrates to reconstituted inside-out Na+,K+-ATPase. CPZ increased oxonol VI fluorescence in the absence of K+, reflecting increased Na+ efflux through the pump. Surprisingly, CPZ induced an ATP-independent increase in fluorescence in the presence of high extravesicular K+, likely indicating opening of an intracellular pathway selective for K+. As revealed by the recent crystal structure of the E1.AlF4-.ADP.3Na+ form of the pig kidney Na+,K+-ATPase, movements of M5 of the α-subunit, which regulate ion selectivity, are controlled by the C-terminal tail that extends from M10. We propose that movements of M10 and its cytoplasmic extension is affected by CPZ, thereby regulating ion selectivity and transport through the K+ sites in Na+,K+-ATPase.


Subject(s)
Capsaicin/analogs & derivatives , Catalytic Domain , Cell Membrane/drug effects , Ion Channel Gating/drug effects , Potassium/metabolism , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Sodium-Potassium-Exchanging ATPase/metabolism , 4-Nitrophenylphosphatase/antagonists & inhibitors , 4-Nitrophenylphosphatase/metabolism , Animals , Biological Transport/drug effects , Capsaicin/pharmacology , Cell Membrane/enzymology , Endopeptidase K/metabolism , Enzyme Inhibitors/pharmacology , Hydrogen-Ion Concentration , Hydrolysis/drug effects , Intracellular Space/drug effects , Intracellular Space/metabolism , Isoxazoles/metabolism , Myocytes, Cardiac/cytology , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , Proteolysis/drug effects , Rats , Sodium/metabolism , Sodium-Potassium-Exchanging ATPase/chemistry , Temperature , Trypsin/metabolism , Vanadates/pharmacology
2.
J Membr Biol ; 216(1): 49-59, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17572836

ABSTRACT

The interactions of divalent cations with the adenosine triphosphatase (ATPase) and para-nitrophenyl phosphatase (pNPPase) activity of the purified dog kidney Na pump and the fluorescence of fluorescein isothiocyanate (FITC)-labeled pump were determined. Sr(2+) and Ba(2+) did not compete with K(+) for ATPase (an extracellular K(+) effect). Sr(2+) and Ba(2+) did compete with Na(+) for ATPase (an intracellular Na(+) effect) and with K(+) for pNPPase (an intracellular K(+) effect). These results suggest that Ba(2+) or Sr(2+) can bind to the intracellular transport site, yet neither Ba(2+) nor Sr(2+) was able to activate pNPPase activity; we confirmed that Ca(2+) and Mn(2+) did activate. As another measure of cation binding, we observed that Ca(2+) and Mn(2+), but not Ba(2+), decreased the fluorescence of the FITC-labeled pump; we confirmed that K(+) substantially decreased the fluorescence. Interestingly, Ba(2+) did shift the K(+) dose-response curve. Ethane diamine inhibited Mn(2+) stimulation of pNPPase (as well as K(+) and Mg(2+) stimulation) but did not shift the 50% inhibitory concentration (IC(50)) for the Mn(2+)-induced fluorescence change of FITC, though it did shift the IC(50) for the K(+)-induced change. These results suggest that the Mn(2+)-induced fluorescence change is not due to Mn(2+) binding at the transport site. The drawbacks of models in which Mn(2+) stimulates pNPPase by binding solely to the catalytic site vs. those in which Mn(2+) stimulates by binding to both the catalytic and transport sites are presented. Our results provide new insights into the pNPPase kinetic mechanism as well as how divalent cations interact with the Na pump.


Subject(s)
4-Nitrophenylphosphatase/metabolism , Calcium/metabolism , Cations, Divalent/metabolism , Sodium-Potassium-Exchanging ATPase/metabolism , 4-Nitrophenylphosphatase/antagonists & inhibitors , Animals , Barium/metabolism , Binding Sites , Dogs , Ethylenediamines/pharmacology , Fluorescein-5-isothiocyanate , Kidney/enzymology , Magnesium/metabolism , Manganese/metabolism , Ouabain/pharmacology , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Strontium/pharmacology
3.
Biochim Biophys Acta ; 1768(7): 1777-83, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17540337

ABSTRACT

The purified PMCA supplemented with phosphatidylcholine was able to hydrolyze pNPP in a reaction media containing only Mg(2+) and K(+). Micromolar concentrations of Ca(2+) inhibited about 75% of the pNPPase activity while the inhibition of the remainder 25% required higher Ca(2+) concentrations. Acidic lipids increased 5-10 fold the pNPPase activity either in the presence or in the absence of Ca(2+). The activation by acidic lipids took place without a significant change in the apparent affinities for pNPP or K(+) but the apparent affinity of the enzyme for Mg(2+) increased about 10 fold. Thus, the stimulation of the pNPPase activity of the PMCA by acidic lipids was maximal at low concentrations of Mg(2+). Although with differing apparent affinities vanadate, phosphate, ATP and ADP were all inhibitors of the pNPPase activity and their effects were not significantly affected by acidic lipids. These results indicate that (a) the phosphatase function of the PMCA is optimal when the enzyme is in its activated Ca(2+) free conformation (E2) and (b) the PMCA can be activated by acidic lipids in the absence of Ca(2+) and the activation improves the interaction of the enzyme with Mg(2+).


Subject(s)
4-Nitrophenylphosphatase/metabolism , Calcium-Transporting ATPases/metabolism , Calcium/physiology , Cell Membrane/enzymology , Lipids/pharmacology , Magnesium/metabolism , 4-Nitrophenylphosphatase/antagonists & inhibitors , 4-Nitrophenylphosphatase/blood , Adenosine Diphosphate/pharmacology , Adenosine Triphosphate/pharmacology , Animals , Brain Chemistry , Calcium-Transporting ATPases/blood , Cattle , Enzyme Activation , Phosphates/pharmacology , Phosphatidylcholines/pharmacology , Potassium/pharmacology , Swine , Vanadates/pharmacology
4.
Blood Cells Mol Dis ; 39(1): 7-13, 2007.
Article in English | MEDLINE | ID: mdl-17459735

ABSTRACT

We examined the effect of extracellular terbium (Tb(3+)) and divalent metal cations (Ca(2+), Sr(2+), and Ba(2+)) on (86)Rb(+) influx into rabbit and human red blood cells. We found that Tb(3+) at 15 and 25 microM was a non-competitive inhibitor of (86)Rb(+) influx suggesting that Tb(3+) is not binding to the transport site. This result reduces the usefulness of Tb(3+) as a potential probe for the E(out) conformation (the conformation with the transport site facing extracellularly). Ba(2+), Sr(2+) and Ca(2+), at concentrations >50 mM, had minimal effects on Rb(+) influx into red blood cells (1 mM Rb-out). This suggests that the outside transport site is very specific for monovalent cations over divalent cations, in contrast to the inside transport site. We also found that chrysoidine (4-phenylazo-m-phenylenediamine) competes with Na(+) for ATPase activity and K(+) for pNPPase activity suggesting it is binding to the E(in) conformation. Chrysoidine and similar compounds may be useful as optical probes of the E(in) conformation.


Subject(s)
4-Nitrophenylphosphatase/metabolism , Erythrocytes/enzymology , Kidney/enzymology , Sodium-Potassium-Exchanging ATPase/metabolism , Terbium/pharmacology , p-Aminoazobenzene/analogs & derivatives , 4-Nitrophenylphosphatase/antagonists & inhibitors , Animals , Cations, Divalent/metabolism , Dose-Response Relationship, Drug , Erythrocytes/cytology , Humans , Ion Transport/drug effects , Rabbits , Sheep , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , p-Aminoazobenzene/pharmacology
5.
Biochemistry ; 43(15): 4559-67, 2004 Apr 20.
Article in English | MEDLINE | ID: mdl-15078102

ABSTRACT

The KdpFABC complex of Escherichia coli, which belongs to the P-type ATPase family, has a unique structure, since catalytic activity (KdpB) and the capacity to transport potassium ions (KdpA) are located on different subunits. We found that fluorescein 5-isothiocyanate (FITC) inhibits ATPase activity, probably by covalently modifying lysine 395 in KdpB. In addition, we observed that the KdpFABC complex is able to hydrolyze p-nitrophenyl phosphate (pNPP) in a Mg(2+)-dependent reaction. The pNPPase activity is inhibited by FITC and o-vanadate. Low concentrations of ATP (1-30 microM) stimulate the pNPPase activity, while concentrations of >500 microM are inhibitory. This behavior can be explained either by a regulatory ATP binding site, where ATP hydrolysis is required, or by proposing an interactive dimer. The notion that FITC inhibits pNPPase and ATPase activity supports the idea that the catalytic domain of KdpB is much more compact than other P-type ATPases, like Na(+),K(+)-ATPase, H(+),K(+)-ATPase, and Ca(2+)-ATPase.


Subject(s)
4-Nitrophenylphosphatase/metabolism , Adenosine Triphosphatases/metabolism , Cation Transport Proteins/metabolism , Escherichia coli Proteins/metabolism , Fluorescein-5-isothiocyanate/chemistry , 4-Nitrophenylphosphatase/antagonists & inhibitors , 4-Nitrophenylphosphatase/chemistry , Adenosine Diphosphate/chemistry , Adenosine Monophosphate/chemistry , Adenosine Triphosphatases/antagonists & inhibitors , Adenosine Triphosphatases/chemistry , Adenosine Triphosphate/chemistry , Amino Acid Motifs , Amino Acid Sequence , Binding Sites , Cation Transport Proteins/antagonists & inhibitors , Cation Transport Proteins/chemistry , Conserved Sequence , Enzyme Activation , Escherichia coli Proteins/antagonists & inhibitors , Escherichia coli Proteins/chemistry , Fluorescent Dyes/chemistry , Lysine/chemistry , Molecular Sequence Data , Substrate Specificity , Vanadates/chemistry
6.
Regul Pept ; 101(1-3): 183-7, 2001 Sep 15.
Article in English | MEDLINE | ID: mdl-11495695

ABSTRACT

Neurotensin (NT), a 13-amino acid peptide, is widely distributed in the brain and peripheral tissues of several mammalian species including man. In adult rat brain NT can bind to two distinct sites, one of high and the other of low affinity, corresponding to NT(1) and NT(2) receptor, respectively; structurally unrelated to these two, a third NT receptor (NT(3)) has been described. We have previously shown that Na(+), K(+)-ATPase is inhibited by NT when using ATP as substrate. In order to determine whether K(+)-stimulated dephosphorylation of this enzyme is involved, we tested NT effect by using p-nitrophenylphosphate, a non-natural substrate. K(+)-p-nitrophenylphosphatase activity was inhibited 42% by NT at 8.6 x 10(-6) M using an incubation medium containing 2 mM KCl but was unaffected in the presence of 5 or 20 mM KCl; however, with such KCl concentrations, NT was enabled to inhibit enzyme activity ( congruent with 35%) provided a suitable ATP:NaCl mixture (0.6:45.0 mM) was added. Mg(2+)-p-nitrophenylphosphatase activity remained unaltered at all conditions tested. Since SR 48692, a selective non-peptide NT(1) antagonist, abolished NT effect, involvement of NT(1) receptor in enzyme inhibition is suggested.


Subject(s)
4-Nitrophenylphosphatase/antagonists & inhibitors , Neurotensin/pharmacology , Potassium/pharmacology , Receptors, Neurotensin/physiology , 4-Nitrophenylphosphatase/metabolism , Adenosine Triphosphate/metabolism , Animals , Kinetics , Magnesium/pharmacology , Male , Nitrophenols/metabolism , Organophosphorus Compounds/metabolism , Phosphorylation , Pyrazoles/pharmacology , Quinolines/pharmacology , Rats , Rats, Wistar , Receptors, Neurotensin/antagonists & inhibitors , Synaptosomes/drug effects , Synaptosomes/enzymology
7.
Arch Biochem Biophys ; 375(2): 304-14, 2000 Mar 15.
Article in English | MEDLINE | ID: mdl-10700386

ABSTRACT

In this work, we describe the ability of living cells of Entamoeba histolytica to hydrolyze extracellular ATP. In these intact parasites, whose viability was determined by motility and by the eosin method, ATP hydrolysis was low in the absence of any divalent metal (78 nmol P(i)/h/10(5) cells). Interestingly, in the presence of 5 mM MgCl(2) an ecto-ATPase activity of 300 nmol P(i)/h/10(5) cells was observed. The addition of MgCl(2) to the extracellular medium increased the ecto-ATPase activity in a dose-dependent manner. At 5 mM ATP, half-maximal stimulation of ATP hydrolysis was obtained with 1.23 mM MgCl(2). Both activities were linear with cell density and with time for at least 1 h. The ecto-ATPase activity was also stimulated by MnCl(2) and CaCl(2) but not by SrCl(2), ZnCl(2), or FeCl(3). In fact, FeCl(3) inhibited both Mg(2+)-dependent and Mg(2+)-independent ecto-ATPase activities. The Mg(2+)-independent ATPase activity was unaffected by pH in the range between 6.4 and 8. 4, in which the cells were viable. However, the Mg(2+)-dependent ATPase activity was enhanced concomitantly with the increase in pH. In order to discard the possibility that the ATP hydrolysis observed was due to phosphatase or 5'-nucleotidase activities, several inhibitors for these enzymes were tested. Sodium orthovanadate, sodium fluoride, levamizole, and ammonium molybdate had no effect on the ATPase activities. In the absence of Mg(2+) (basal activity), the apparent K(m) for ATP(4-) was 0.053 +/- 0.008 mM, whereas at saturating MgCl(2) concentrations, the corresponding apparent K(m) for Mg-ATP(2-) for Mg(2+)-dependent ecto-ATPase activity (difference between total and basal ecto-ATPase activity) was 0.503 mM +/- 0.062. Both ecto-ATPase activities were highly specific for ATP and were also able to hydrolyze ADP less efficiently. To identify the observed hydrolytic activities as those of an ecto-ATPase, we used suramin, a competitive antagonist of P(2) purinoreceptors and an inhibitor of some ecto-ATPases, as well as the impermeant agent 4'-4'-diisothiocyanostylbenzene-2'-2'-disulfonic acid. These two reagents inhibited the Mg(2+)-independent and the Mg(2+)-dependent ATPase activities to different extents, and the inhibition by both agents was prevented by ATP. A comparison among the ecto-ATPase activities of three amoeba species showed that the noninvasive E. histolytica and the free-living E. moshkovskii were less efficient than the pathogenic E. histolytica in hydrolyzing ATP. As E. histolytica is known to have a galactose-specific lectin on its surface, which is related to the pathogenesis of amebiasis, galactose was tested for an effect on ecto-ATPase activities. It stimulated the Mg(2+)-dependent ecto-ATPase but not the Mg(2+)-independent ATPase activity.


Subject(s)
Adenosine Triphosphatases/metabolism , Entamoeba histolytica/enzymology , 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid/pharmacology , 4-Nitrophenylphosphatase/antagonists & inhibitors , 4-Nitrophenylphosphatase/metabolism , 5'-Nucleotidase/antagonists & inhibitors , 5'-Nucleotidase/metabolism , Adenosine Triphosphatases/antagonists & inhibitors , Adenosine Triphosphate/metabolism , Adenosine Triphosphate/pharmacology , Animals , Cations, Divalent/antagonists & inhibitors , Cations, Divalent/pharmacology , Dose-Response Relationship, Drug , Entamoeba/cytology , Entamoeba/drug effects , Entamoeba/enzymology , Entamoeba histolytica/cytology , Entamoeba histolytica/drug effects , Entamoeba histolytica/pathogenicity , Enzyme Activation/drug effects , Galactose/pharmacology , Hydrogen-Ion Concentration , Hydrolysis/drug effects , Kinetics , Magnesium/antagonists & inhibitors , Magnesium/pharmacology , Substrate Specificity , Suramin/pharmacology
8.
J Med Chem ; 43(5): 995-1010, 2000 Mar 09.
Article in English | MEDLINE | ID: mdl-10715163

ABSTRACT

Insulin resistance in the liver and peripheral tissues together with a pancreatic cell defect are the common causes of type 2 diabetes. It is now appreciated that insulin resistance can result from a defect in the insulin receptor signaling system, at a site post binding of insulin to its receptor. Protein tyrosine phosphatases (PTPases) have been shown to be negative regulators of the insulin receptor. Inhibiton of PTPases may be an effective method in the treatment of type 2 diabetes. A series of azolidinediones has been prepared as protein tyrosine phosphatase 1B (PTP1B) inhibitors. Several compounds were potent inhibitors against the recombinant rat and human PTP1B enzymes with submicromolar IC(50) values. Elongated spacers between the azolidinedione moiety and the central aromatic portion of the molecule as well as hydrophobic groups at the vicinity of this aromatic region were very important to the inhibitory activity. Oxadiazolidinediones 87 and 88 and the corresponding acetic acid analogues 119 and 120 were the best h-PTP1B inhibitors with IC(50) values in the range of 0.12-0.3 microM. Several compounds normalized plasma glucose and insulin levels in the ob/ob and db/db diabetic mouse models.


Subject(s)
Enzyme Inhibitors/chemical synthesis , Hypoglycemic Agents/chemical synthesis , Membrane Proteins/antagonists & inhibitors , Oxazoles/chemical synthesis , Protein Tyrosine Phosphatases/antagonists & inhibitors , 4-Nitrophenylphosphatase/antagonists & inhibitors , Animals , Blood Glucose/metabolism , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/genetics , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Humans , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/pharmacology , In Vitro Techniques , Insulin/blood , Liver/drug effects , Liver/enzymology , Male , Mice , Mice, Obese , Oxazoles/chemistry , Oxazoles/pharmacology , Protein Tyrosine Phosphatase, Non-Receptor Type 1 , Rats , Rats, Sprague-Dawley , Recombinant Proteins/antagonists & inhibitors , Structure-Activity Relationship
9.
Biochem Pharmacol ; 59(7): 881-6, 2000 Apr 01.
Article in English | MEDLINE | ID: mdl-10718347

ABSTRACT

Hinesol, a major component of the crude drug "So-jutsu" (Atractylodis Lanceae Rhizoma), strongly inhibited H+,K+-ATPase activity with a IC50 value of 5.8x10(-5) M. It also inhibited Na+,K+-ATPase, Mg2+-ATPase, Ca2+-ATPase, and H+-ATPase activities, although the inhibition rate was lower. No effects on alkaline or acid phosphatase activities were observed. The mechanism by which hinesol inhibited H+,K+-ATPase activity was studied in detail. The inhibition was uncompetitive with respect to ATP, and it increased as the Mg2+ concentration was raised, whereas it was not affected by the K+ concentration. The activity of K+-dependent p-nitrophenyl phosphatase (K+-pNPPase), a partial reaction of H+,K+-ATPase, was inhibited by hinesol noncompetitively with respect to pNPP (IC50 value of 1.6x10(-4) M), and competitively with respect to K+, whereas it was not affected by the Mg2+ concentration. These results suggest that hinesol is a relatively specific inhibitor of H+,K+-ATPase. It appears that hinesol reacts with enzyme in the E1 state in the presence of ATP and Mg2+ and forms the complex hinesol-H+ E1-ATP or hinesol x E1-P, blocking the conformational change to the E2 state. Furthermore, hinesol enhanced the inhibitory effect of omeprazole on H+,K+-ATPase, and the inhibitory site of hinesol was different from that of omeprazole. The effect of So-jutsu as an anti-gastric ulcer agent may be ascribed to the inhibitory effect of hinesol on H+,K+-ATPase activity.


Subject(s)
Drugs, Chinese Herbal/chemistry , Enzyme Inhibitors/pharmacology , Proton Pump Inhibitors , Spiro Compounds/pharmacology , 4-Nitrophenylphosphatase/antagonists & inhibitors , 4-Nitrophenylphosphatase/metabolism , Adenosine Triphosphatases/antagonists & inhibitors , Adenosine Triphosphatases/metabolism , Animals , In Vitro Techniques , Ligands , Medicine, Chinese Traditional , Omeprazole/pharmacology , Phosphoric Monoester Hydrolases/antagonists & inhibitors , Phosphoric Monoester Hydrolases/metabolism , Sesquiterpenes , Swine
10.
Am J Hypertens ; 12(4 Pt 1): 364-73, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10232496

ABSTRACT

It has been demonstrated that human plasma contains a low molecular weight sodium-potassium-stimulated adenosine triphosphatase (Na-K-ATPase) inhibitor, which can be dissociated from a circulating protein with a molecular weight of approximately 12,000 daltons. The dissociated factor was found to have a molecular weight <500 daltons, and shared many characteristics with ouabain. Similar to ouabain, this factor was found to be a potent inhibitor of both the Na-K-ATPase and potassium-stimulated para-nitrophenyl phosphatase (K-pNPPase) enzyme systems, and to bind to both high- and low-affinity binding sites on Na-K-ATPase, but unlike ouabain did not cross-react with digoxin antibody. The factor was further separated by HPLC and electrochemical detection into two active compounds (p-NKAI-1 and p-NKAI-2). P-NKAI-1 was demonstrated on mass spectroscopy to have a molecular weight of 408 daltons. In a vasoconstrictor assay employing rabbit femoral artery segments, this compound was a direct vasoconstrictor and potentiated the vasoconstriction produced by norepinephrine. It behaved similarly to ouabain in counteracting the relaxing effect on rabbit femoral artery of increasing potassium concentrations in the tissue bath.


Subject(s)
Blood Proteins/isolation & purification , Enzyme Inhibitors/blood , Hypertension/blood , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , 4-Nitrophenylphosphatase/antagonists & inhibitors , Animals , Binding, Competitive , Blood Proteins/chemistry , Digoxin/immunology , Electrophoresis, Polyacrylamide Gel , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Femoral Artery/drug effects , Femoral Artery/physiology , Humans , In Vitro Techniques , Male , Mass Spectrometry , Molecular Weight , Ouabain/metabolism , Ouabain/pharmacology , Rabbits , Radioimmunoassay , Sodium-Potassium-Exchanging ATPase/metabolism , Tritium , Vasoconstriction/drug effects
11.
Acta Otolaryngol ; 118(6): 817-20, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9870626

ABSTRACT

On the basolateral infoldings of the strial marginal cells in the cochlea, Na K ATPase activity is abundant. To clarify the humoral control by norepinephrine, K-NPPase activity of strial marginal cells in the cochlea was investigated in normal, reserpine, norepinephrine (NE), reserpine plus NE-treated guinea pigs using a cerium-based method. K-NPPase activity was almost completely decreased 3-20 days after reserpine administration. At 10 days after reserpinization and following NE repeated treatment, enzyme activity was detectable. These results suggested that norepinephrine might restore and regulate strial K-NPPase activity.


Subject(s)
4-Nitrophenylphosphatase/drug effects , Adrenergic Uptake Inhibitors/pharmacology , Adrenergic alpha-Agonists/pharmacology , Enzyme Inhibitors/pharmacology , Norepinephrine/pharmacology , Ouabain/pharmacology , Reserpine/pharmacology , Stria Vascularis/enzymology , 4-Nitrophenylphosphatase/antagonists & inhibitors , Animals , Cerium , Cytoplasm/drug effects , Cytoplasm/enzymology , Cytoplasm/ultrastructure , Enzyme Reactivators/pharmacology , Guinea Pigs , Histocytochemistry , Microscopy, Electron , Sodium-Potassium-Exchanging ATPase/drug effects , Stria Vascularis/drug effects , Stria Vascularis/ultrastructure
12.
J Exp Biol ; 201(Pt 1): 81-9, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9390939

ABSTRACT

Fatty acids from two strains of the cyanobacterium Microcystis aeruginosa, PCC 7820 (a strain that produces the hepatotoxin microcystin-LR, MC-LR) and CYA 43 (a strain that produces only small quantities of MC-LR), were extracted, partially characterised and tested for their inhibitory effect on the K+-dependent p-nitrophenol phosphatase (pNPPase) activity of tilapia (Oreochromis mossambicus) gill basolateral membrane. Thin-layer chromatography of the lipids from dichloromethane:methanol extracts of M. aeruginosa PCC 7820 and CYA 43, using diethylether:isopropanol:formic acid (100:4.5:2.5) as solvent, yielded five inhibitory products from M. aeruginosa 7820 and six from M. aeruginosa CYA 43. None of these products could be related to MC-LR. The inhibitory behaviour of the products mimics that of a slow, tight-binding inhibitor. The inhibitory activity is removed by incubation of extracts with fatty-acid-free bovine serum albumin (FAF-BSA). However, FAF-BSA only partially reversed the inhibition of K+-dependent pNPPase on fish gills pre-exposed to the extracted products. We conclude that M. aeruginosa strains PCC 7820 and CYA 43 produce fatty acids with potent inhibitory effects on K+-dependent pNPPase. The release of these products following lysis of cyanobacterial blooms may help to explain fish kills through a disturbance of gill functioning.


Subject(s)
Enzyme Inhibitors/pharmacology , Fatty Acids/pharmacology , Gills/enzymology , Microcystis/chemistry , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Tilapia , 4-Nitrophenylphosphatase/antagonists & inhibitors , Animals , Fatty Acids/isolation & purification , Potassium/pharmacology , Serum Albumin, Bovine/pharmacology
13.
Biochem Biophys Res Commun ; 253(1): 164-9, 1998 Dec 09.
Article in English | MEDLINE | ID: mdl-9875238

ABSTRACT

In the present work ecto-phosphatase activity in Herpetomonas muscarum muscarum has been characterized using live parasites. This enzyme hydrolyzed p-nitrophenylphosphate at a rate of 4.27 nmol Pi/mg of protein.min. A pH curve was generated, in which these intact flagellates showed the highest phosphatase activity at pH 6.5. Classical inhibitors for acid phosphatase, such as sodium orthovanadate, sodium tartrate, and ammonium molybdate, were used in the experiments and showed different patterns of inhibition. Lithium fluoride, aluminum chloride, and fluoroaluminate complexes were also tested. Although lithium fluoride and fluoroaluminate complexes were capable of inhibiting the phosphatase activity, aluminum chloride stimulated this enzyme. Cytochemical analysis showed the localization of this enzyme on the parasite surface. This ecto-phosphatase activity was also significantly diminished when the parasites were treated with 10(-6) M platelet-activating factor (PAF), a potent phospholipid mediator that promoted cellular differentiation in this parasite.


Subject(s)
4-Nitrophenylphosphatase/antagonists & inhibitors , 4-Nitrophenylphosphatase/metabolism , Platelet Activating Factor/pharmacology , Trypanosomatina/enzymology , Animals , Cell Differentiation/drug effects , Cell-Free System , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Hydrolysis , Kinetics , Trypanosomatina/cytology , Trypanosomatina/drug effects
14.
Biochem Pharmacol ; 53(4): 611-4, 1997 Feb 21.
Article in English | MEDLINE | ID: mdl-9105414

ABSTRACT

The inhibition of Na+,K(+)-ATPase activity by various constituents of Moutan Cortex and Paeoniae Radix was studied. 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose (PGG), a major component of both crude drugs, strongly inhibited Na+,K(+)-ATPase activity (IC50 = 2.5 x 10(-6) M), whereas galloylpaeoniflorin, benzoic acid, and catechin were weakly inhibitory, and albiflorin, oxypaeoniflorin, paeoniflorin, paconol, and phenol were ineffective. The inhibition of Na+,K(+)-ATPase activity by PGG was decreased in the presence of BSA or phospholipids. The inhibition mode of PGG was noncompetitive with respect to ATP. The K0.5 value for Na+ was increased by the addition of PGG from 9.1 to 12.3 mM, whereas that for K+ was not altered. PGG also inhibited K(+)-dependent p-nitrophenyl phosphatase activity with an IC50 value of 5.3 x 10(-6) M, and the extent of the inhibition increased at higher concentrations of K+. The K0.5 value for K+ was decreased by the addition of PGG from 3.3 to 2.0 mM. These results suggested that the inhibition of Na+,K(+)-ATPase activity is caused by interaction of PGG with the enzyme in the E2 state. The inhibitory effect of Moutan Cortex or Paeoniae Radix is considered to be mainly attributable to PGG.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Enzyme Inhibitors/pharmacology , Hydrolyzable Tannins , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Tannins/pharmacology , 4-Nitrophenylphosphatase/antagonists & inhibitors , Animals , Dose-Response Relationship, Drug , Horses
15.
Biol Pharm Bull ; 20(12): 1235-9, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9448095

ABSTRACT

Human liver contains high molecular weight-type Zn2+-dependent acid p-nitrophenylphosphatase (HMW-ZnAP). The enzyme was purified 1000-fold by a new procedure, including preparative isoelectrofocusing. The HMW-ZnAP was homogeneous in non-denaturing disk-gel electrophoresis with an MW of about 93 kDa determined by Sephadex G-100 chromatography. A single polypeptide chain of 43 kDa was detected on sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), suggesting a homodimeric structure. The isoelectric point (pI) was 7.2-7.4. Human liver HMW-ZnAP requires Zn2+-ions for activity; other divalent cations are ineffective or act as inhibitors. It dephosphorylated p-nitrophenylphosphate (pNPP) (Km = 0.24 mM), o-carboxyl phenylphosphate (oCPP) (Km = 0.92 mM) and phenylphosphate (PhP) (Km = 1.42 mM). Other substrates including [32P]-labelled casein or phosvitin, adenyl nucleotides and myo-inositol-1-phosphate, were not dephosphorylated. Human liver HMW-ZnAP obeys Michaelis-Menten kinetics with pNPP as substrate; the enzyme was competitively inhibited by inorganic phosphate (Ki = 0.55 mM), and by oCPP (Ki = 0.65 mM) and PhP (K = 1.16 mM). Adenosine monophosphate (AMP), adenosine diphosphate (ADP) and ATP displayed mixed-type inhibition. The enzyme was also inhibited by some modifiers such as EDTA, oxalate, p-chloromercurybenzoate, tartrate, imidazole, cyanide, cysteine, histidine and diethylpyrocarbonate, but not by fluoride or okadaic acid. Human liver HMW-ZnAP is sensitive to temperatures higher than 40 degrees C. The pH-dependence of the steady-state kinetic parameters indicates the existence of an essential ionizable group with a pKa of 7.25-7.50, similar to that of histidine. However, diethylpyrocarbonate inactivation experiments suggest that other amino acid residues may also be involved in enzyme catalysis.


Subject(s)
4-Nitrophenylphosphatase/isolation & purification , Liver/enzymology , Zinc/metabolism , 4-Nitrophenylphosphatase/analysis , 4-Nitrophenylphosphatase/antagonists & inhibitors , Animals , Cattle , Electrophoresis, Polyacrylamide Gel , Enzyme Inhibitors/pharmacology , Humans , Hydrogen-Ion Concentration , Indicators and Reagents , Isoelectric Focusing , Kinetics , Molecular Weight , Substrate Specificity , Temperature
16.
Toxicol Lett ; 87(1): 31-8, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8701442

ABSTRACT

The interaction of Cu2+ with enzymatic activity of rabbit kidney Na+/K(+)-ATPase was studied in media with buffered, defined free Cu2+ levels. The IC50-values are 0.1 mumol/l for Na+/K(+)-ATPase and 1 mumol/l for K(+)-pNPPase. Dithiothreitol (DTT) reverses the inhibitory effect of Cu2+ in vitro. Cu2+ exerts non-competitive effects on the enzyme with respect to Na+, K+, ATP or pNPP, but has a mixed-type inhibitory effect with respect to Mg2+. It is concluded that the appreciation of the inhibitory effect of Cu2+ on this enzyme requires carefully composed assay media that include a buffer for Cu2+, and that the IC50-values calculated according to this model indicate that Cu2+ may be more toxic than previously anticipated.


Subject(s)
Copper/pharmacology , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , 4-Nitrophenylphosphatase/antagonists & inhibitors , 4-Nitrophenylphosphatase/metabolism , Animals , Dithiothreitol/pharmacology , In Vitro Techniques , Kidney/enzymology , Magnesium/analysis , Rabbits , Sodium-Potassium-Exchanging ATPase/metabolism , Substrate Specificity
17.
J Cell Physiol ; 167(3): 461-8, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8655600

ABSTRACT

The mitogenic effect of recombinant human erythropoietin (rHuEpo) on primary cultures of neonatal rat cardiac myocytes was observed. rHuEpo triggered a dose-dependent increase in myocyte proliferation. The hormone effect over optimally grown control culture 1 day after addition was maximum with 0.5 U/ml and was inhibited with anti-rHuEpo. Inhibitors of enzymatic pathways known to be involved in the cytokines intracellular mechanism such as genistein (tyrosine kinase inhibitor), 2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate (phospholipase C [PLC] inhibitor), and 1-(5-isoquinolinylsulfonyl)-2-methyl-piperazine (protein kinase C [PKC] inhibitor) prevented the mitogenic action of rHuEpo. Also the inhibition of Na(+)-K(+)-ATPase activity by ouabain blunted the stimulatory action of rHuEpo on cell proliferation. The mitogenic action of the hormone was correlated with cardiac membrane paranitrophenylphosphatase (pNPPase) and PKC activity, since concentrations of rHuEpo that stimulate DNA synthesis increased pNPPase and PKC activity. Moreover, the enzymatic inhibition of tyrosine kinase, PLC, and PKC attenuated the stimulatory action of rHuEpo upon cardiac pNPPase activity. In this paper we demonstrate a non-hematopoietic action of rHuEpo showing both mitogenic and enzymatic effect upon primary myocyte cell culture and on pNPPase activity of neonatal rat heart. These effects are related to the capacity of rHuEpo to stimulate Na(+)-K(+)-ATPase activity and appear to be secondary to the activation of tyrosine kinase and PKC, indicating that in the rHuEpo mediated mitogenic action on cardiomyocytes involves the activation of the same enzymatic pathways that have been described by other cytokines in different tissues.


Subject(s)
Erythropoietin/pharmacology , Mitogens/pharmacology , Myocardium/metabolism , Signal Transduction/genetics , 4-Nitrophenylphosphatase/antagonists & inhibitors , 4-Nitrophenylphosphatase/metabolism , Animals , Antibodies/immunology , Antibodies/pharmacology , Cell Division/drug effects , Cells, Cultured , DNA/biosynthesis , Enzyme Inhibitors/pharmacology , Genistein , Humans , Isoflavones/pharmacology , Myocardium/cytology , Ouabain/pharmacology , Protein Kinase C/metabolism , Rats , Rats, Wistar , Recombinant Proteins/pharmacology , Tetradecanoylphorbol Acetate/pharmacology
18.
Neurosci Res ; 24(3): 309-12, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8815450

ABSTRACT

Using Mayahara's method, the distribution of K(+)-dependent p-nitrophenylphosphatase activity was examined electron microscopically in the synaptic regions of the cerebral cortex of 10, 15 and 60-day-old Wistar rats. The enzyme achieved gradually its characteristic localization and uniform distribution. The main developmental changes were associated with the establishment of the postsynaptic density's activity. The controls with ouabain revealed activity only on the postsynaptic densities.


Subject(s)
4-Nitrophenylphosphatase/metabolism , Cerebral Cortex/enzymology , Potassium/physiology , Sodium-Potassium-Exchanging ATPase/metabolism , Synapses/enzymology , 4-Nitrophenylphosphatase/antagonists & inhibitors , Animals , Cerebral Cortex/ultrastructure , Enzyme Inhibitors/pharmacology , Microscopy, Electron , Ouabain/pharmacology , Rats , Rats, Wistar , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Synapses/ultrastructure , Synaptic Membranes/enzymology , Synaptic Membranes/ultrastructure , Synaptic Vesicles/enzymology , Synaptic Vesicles/ultrastructure
19.
Biochem Pharmacol ; 51(3): 339-43, 1996 Feb 09.
Article in English | MEDLINE | ID: mdl-8573201

ABSTRACT

Atractylon, a major component of the crude drug "Byaku-jutsu" (rhizomes of Atractylodes japonica), strongly inhibited Na+,K(+)-ATPase activity with an I50 value of 8.9 x 10(-6) M. It also inhibited Mg(2+)-ATPase, H+,K(+)-ATPase, H(+)-ATPase and Ca(2+)-ATPase activities, but less potently. No effects on alkaline and acid phosphatase activities were observed. The inhibition of Na+,K(+)-ATPase activity by atractylon was noncompetitive with respect to ATP and was greater with increasing K+ concentration, whereas it was not affected by Na+ concentration. The activity of K(+)-dependent p-nitrophenyl phosphatase, a partial reaction of Na+,K(+)-ATPase, was inhibited noncompetitively with respect to substrate (I50 value of 1.8 x 10(-5) M), and the inhibition rate was independent of the K+ concentration. Furthermore, atractylon increased the Ki value for Na+ from 130 to 190 mM, but did not alter the Ki value for ATP. Inhibition of the phosphoenzyme formation by atractylon was greater at 0.1 M than at 1 M NaCl. K(+)-dependent dephosphorylation (E2-P to K.E2) was inhibited by atractylon, whereas ADP-sensitive (Na.E1-P to Na.E1) and non-specific dephosphorylation steps were not affected. These results suggest that atractylon, a specific inhibitor of Na+,K(+)-ATPase, interacts with enzyme in the E2 state and inhibits the reaction step from E2-P to K.E2.


Subject(s)
Plants, Medicinal , Sesquiterpenes/pharmacology , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , 4-Nitrophenylphosphatase/antagonists & inhibitors , Animals , Gastric Mucosa/enzymology , Horses , Kidney/enzymology , Medicine, Chinese Traditional , Phosphorylation/drug effects , Potassium Chloride/pharmacology , Rats , Sodium Chloride/pharmacology , Sodium-Potassium-Exchanging ATPase/isolation & purification
20.
Neurochem Int ; 27(4-5): 319-27, 1995.
Article in English | MEDLINE | ID: mdl-8845732

ABSTRACT

Previous work carried out in this laboratory has led to the isolation from rat brain of an aqueous soluble fraction (peak II) inhibiting synaptosomal membrane Na+, K(+)-ATPase and possessing other ouabain-like properties. Brain peak II was subjected to several treatments or fractionation by reversed-phase or anionic exchange HPLC and the effect of resultant fractions tested on synaptosomal membrane ATPase activity. The inhibitory components proved highly hydrophilic since they were neither extracted by hexane nor retained by a C-18 HPLC column, ruling out a lipidic nature. By anionic exchange chromatography, peak II was separated into eight fractions, two of which, named II-A and II-E, presented inhibitory activity, had low molecular weight, reacted with ninhydrin and were sensitive to acid hydrolysis. Fraction II-A was further chromatographed through a C-18 column, rendering five fractions, II-A1 to II-A5, inhibitory activity being confined to the most hydrophilic one (II-A1). Fraction II-E seems non-peptidic in nature, and its inhibitory activity was completed lost by alkalinization. II-E differs from authentic ouabain in u.v. spectrum, chromatographic behaviour and alkali sensitivity. It is suggested that two small hydrophilic compounds, probably one peptidic (II-A1) and another non-peptidic (II-E) in nature are involved in the regulation of Na+, K(+)-ATPase activity at the synaptic membranes.


Subject(s)
Cerebral Cortex/metabolism , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Synaptosomes/metabolism , 4-Nitrophenylphosphatase/antagonists & inhibitors , Adenosine Triphosphatases/antagonists & inhibitors , Animals , Chemical Fractionation , Chromatography, High Pressure Liquid , Female , Hexanes , Male , Rats , Rats, Wistar , Solubility , Subcellular Fractions/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...